A research group at the Alfred Hospital in Melbourne has produced findings that could unlock doors to more effective HIV treatments.
Get the full story...
The first genome-wide association study of an infectious disease, conducted by an international group of researchers through the Center for HIV/AIDS Vaccine Immunology (CHAVI), has yielded a new understanding of why some people can suppress virus levels following HIV infection.
Get the full story...
With HIV infection driving a deadly resurgence of tuberculosis (TB), a new publication provides up-to-date recommendations for clinicians facing the many challenges of treating patients with both of these two complex diseases.
Get the full story...
A growing number of drug-resistant strains of HIV are a threat to the effectiveness of current treatments despite anti-HIV drug cocktails decreasing the number of HIV-related deaths and improving the quality of life for HIV patients.
Get the full story...
In a retrospective study of 700 patients with culture-positive tuberculosis (TB), relapse rates were found to be significantly higher in HIV-infected patients compared to HIV-uninfected patients following a rifamycin-based regimen.
Get the full story...
Despite the success of highly active antiretroviral treatment (HAART), people with HIV may still be at higher risk for nutritional deficiencies and abnormalities. In two different studies, researchers at the Nutrition/Infection Unit in the Department of Public Health and Family Medicine at Tufts University School of Medicine, and colleagues examined the incidence of metabolic syndrome and existing micronutrient deficiencies among participants in the Nutrition for Healthy Living (NFHL) study, a cohort with HIV.
Read the full story
